
aTyr Pharma
(NASDAQ) ATYR
aTyr Pharma Financials at a Glance
Market Cap
$81.15M
Revenue (TTM)
$190.00K
Net Income (TTM)
$74.12M
EPS (TTM)
$-0.80
P/E Ratio
-1.04
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$0.83
Volume
0
Open
$0.82
Price
$0.83
Volume
0
Open
$0.82
Previous Close
$0.83
Daily Range
$0.79 - $0.84
52-Week Range
$0.64 - $7.29
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$0.83
Volume
0
Open
$0.82
Previous Close
$0.83
Daily Range
$0.79 - $0.84
52-Week Range
$0.64 - $7.29
ATYR News
ATYR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout aTyr Pharma
Industry
Biotechnology
Sector
Health CareEmployees
58
CEO
Sanjay S. Shukla, MD
Website
www.atyrpharma.comHeadquarters
San Diego, CA 92121, US
ATYR Financials
Key Financial Metrics (TTM)
Gross Margin
-118%
Operating Margin
-409%
Net Income Margin
-390%
Return on Equity
-108%
Return on Capital
-98%
Return on Assets
-79%
Earnings Yield
-96.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$81.15M
Shares Outstanding
98.05M
Volume
0
Short Interest
0.00%
Avg. Volume
1.85M
Financials (TTM)
Gross Profit
$1.36M
Operating Income
$77.63M
EBITDA
$76.07M
Operating Cash Flow
$61.99M
Capital Expenditure
$77.00K
Free Cash Flow
$62.06M
Cash & ST Invst.
$78.69M
Total Debt
$12.03M
aTyr Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$394.00K
+96.8%
Gross Margin
0.00%
N/A
Market Cap
$81.15M
N/A
Market Cap/Employee
$1.45M
N/A
Employees
56
N/A
Net Income
$13.96M
+6.7%
EBITDA
$14.40M
+7.9%
Quarterly Fundamentals
Net Cash
$66.65M
+13.3%
Accounts Receivable
$873.00K
-49.7%
Inventory
$0.00
N/A
Long Term Debt
$10.57M
-12.2%
Short Term Debt
$1.47M
+17.1%
Return on Assets
-78.71%
N/A
Return on Invested Capital
-98.24%
N/A
Free Cash Flow
$12.23M
+7.1%
Operating Cash Flow
$12.20M
+7.1%


